Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06488157 · ClinicalTrials.gov registry record · NA
Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
A NA study of Caregiver Burden, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06488157: Completed NA study of Caregiver Burden, sponsored by Weill Medical College of Cornell University.
NCT06488157 is a NA study of Caregiver Burden that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants, below the 244-participant average among 41 other Caregiver Burden trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06488157, a NA study of Caregiver Burden, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.
Primary Outcome
Feasibility was measured by the percentage of caregivers who enrolled in the study out of all eligible participants.
Conditions Studied
Interventions
- OTHER I-HoME
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-07-10 |
| Est. Completion | 2025-05-23 |
| Phase | NA |
What the finished NCT06488157 record still lists
NCT06488157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 244-participant average among 41 other Caregiver Burden trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Caregiver Burden appearing as the primary indexed condition, and to 1 intervention - of which I-HoME is the first listed.
NCT06488157 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06488157 about?
NCT06488157 is a clinical study titled "Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD". The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility...
What is the current status of trial NCT06488157?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-07-10. Estimated completion is 2025-05-23.
What conditions does trial NCT06488157 study?
This clinical trial studies the following conditions: Caregiver Burden.
What interventions are being tested in trial NCT06488157?
The interventions under investigation include: I-HoME (OTHER).
Who is sponsoring clinical trial NCT06488157?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06488157 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver Burden
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06488157's enrollment target sits among peer trials
15 42nd of 41 the lowest of 41 other Caregiver Burden trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Telephone Support in Advanced Gastrointestinal Cancer
RECRUITING · NA
-
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
RECRUITING · NA
-
DECIDE: Dyads and Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI